Funding from the EU, the Federal Republic of Germany and the federal state of Lower Saxony

This project is funded by the European Regional Development Fund.

At ReliaTech, the quality and activity of the cytokines, soluble receptors and antibodies we produce have always been our top priority. To further enhance our quality standards, we are constantly on the lookout for new methods to ensure we can offer our customers the very best quality. That is why we aim to determine and characterise the interactions between molecules, their stability and batch-to-batch consistency with even greater precision.

The aim is to introduce the Thermal Shift Assay to improve the stability testing, activity testing and purity determination of our molecules.